REATA PHARMACEUTICALS INC Operating Lease, Payments
REATA PHARMACEUTICALS INC reported Operating Lease, Payments of $7.70 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2023-08-08
- REATA PHARMACEUTICALS INC operating lease, payments for the quarter ending 2023-06-30 was $3.80M, a 192.31% increase year-over-year.
- REATA PHARMACEUTICALS INC operating lease, payments for the quarter ending 2023-03-31 was $3.90M, a 387.50% increase year-over-year.
- REATA PHARMACEUTICALS INC operating lease, payments for the quarter ending 2022-12-31 was $3.30M, a 312.50% increase year-over-year.
- REATA PHARMACEUTICALS INC operating lease, payments for the quarter ending 2022-09-30 was $4.10M, a 412.50% increase year-over-year.
- REATA PHARMACEUTICALS INC operating lease, payments for fiscal 2022 was $9.50M, a 196.88% increase from fiscal 2021.
- REATA PHARMACEUTICALS INC operating lease, payments for fiscal 2021 was $3.20M.
- REATA PHARMACEUTICALS INC operating lease, payments for fiscal 2019 was $2.40M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2023-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $7.70M 10-Q · filed 2023-08-08 | $11.00M derived: sum of 3 quarters · filed 2023-08-08 | $15.10M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $3.90M 10-Q · filed 2023-05-10 | $7.20M derived: sum of 2 quarters · filed 2023-05-10 | $11.30M derived: sum of 3 quarters · filed 2023-05-10 | $12.60M derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $7.40M derived: sum of 2 quarters · filed 2023-02-24 | $8.70M derived: sum of 3 quarters · filed 2023-02-24 | $9.50M 10-K · filed 2023-02-24 |
| 2022-09-30 | $4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $5.40M derived: sum of 2 quarters · filed 2022-11-08 | $6.20M 10-Q · filed 2022-11-08 | $7.00M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.10M 10-Q · filed 2022-08-08 | $2.90M derived: sum of 3 quarters · filed 2022-08-08 | $3.70M derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | $800.00K 10-Q · filed 2022-05-10 | $1.60M derived: sum of 2 quarters · filed 2022-05-10 | $2.40M derived: sum of 3 quarters · filed 2022-05-10 | $3.20M derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.60M derived: sum of 2 quarters · filed 2022-02-28 | $2.40M derived: sum of 3 quarters · filed 2022-02-28 | $3.20M 10-K · filed 2022-02-28 |
| 2021-09-30 | $800.00K 10-Q · filed 2021-11-08 | $1.60M derived: sum of 2 quarters · filed 2021-11-08 | $2.40M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $800.00K 10-Q · filed 2021-08-09 | $1.60M 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | $800.00K 10-Q · filed 2021-05-06 | |||
| 2020-09-30 | $700.00K 10-Q · filed 2020-11-09 | $1.70M derived: sum of 2 quarters · filed 2020-11-09 | $2.70M 10-Q · filed 2020-11-09 | $3.33M derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | $1.00M 10-Q · filed 2020-08-10 | $1.90M 10-Q · filed 2020-08-10 | $2.63M derived: sum of 3 quarters · filed 2020-08-10 | $3.35M derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | $900.00K 10-Q · filed 2020-05-11 | $1.63M derived: sum of 2 quarters · filed 2020-05-11 | $2.35M derived: sum of 3 quarters · filed 2020-05-11 | |
| 2019-12-31 | $733.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $1.45M derived: sum of 2 quarters · filed 2020-02-19 | $2.40M 10-K · filed 2020-02-19 | |
| 2019-09-30 | $715.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.67M 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | $952.00K 10-Q · filed 2019-08-08 |